Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial
Titel:
Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial
Auteur:
Kosiborod, Mikhail N Windsor, Sheryl L Vardeny, Orly Berger, Jeffrey S Reynolds, Harmony R Boumakis, Stavroula Althouse, Andrew D Solomon, Scott D Bhatt, Ankeet S Peikert, Alexander Luther, James F Leifer, Eric S Kindzelski, Andrei L Cushman, Mary Ng Gong, Michelle Kornblith, Lucy Z Khatri, Pooja Kim, Keri S Baumann Kreuziger, Lisa Javaheri, Ali Carpio, Carlos Wahid, Lana Lopez-Sendon Moreno, Jose Alonso, Alvaro Ho, Minh Quang Lopez-Sendon, Jose Lopes, Renato D Curtis, Jeffrey L Kirwan, Bridget-Anne Geraci, Mark W Neal, Matthew D Hochman, Judith S